Related Experiment Videos
Functional polymorphisms among HLA-DR4+ DR beta chains associated with limited peptide diversity
C E Seyfried1, P K Gregersen, B S Nepom
1Virginia Mason Research Center, Seattle, WA 98101.
Molecular Immunology
|May 1, 1987
Summary
Human Leukocyte Antigen (HLA) class II polymorphisms, specifically within DR beta chains, show limited structural variation. Distinct peptide variations in DR beta chains correlate with specific HLA-D subtypes, implicating amino acids 66-71.
Area of Science:
- Immunogenetics
- Molecular Biology
- Protein Chemistry
Background:
- Human Leukocyte Antigen (HLA) class II molecules are crucial for immune responses.
- Polymorphisms within HLA genes contribute to immune system diversity and disease susceptibility.
- DR beta chains are key components of HLA-DR molecules, influencing T-cell recognition.
Purpose of the Study:
- To investigate the structural variations within DR beta chains associated with different HLA-DR specificities.
- To identify specific regions of the DR beta chain responsible for HLA-D polymorphisms.
- To correlate peptide map variations with nucleotide sequences and amino acid changes.
Main Methods:
- High-pressure liquid chromatography (HPLC) analysis of tryptic peptide maps.
- Radiolabeling (3H-leucine) of cellular proteins.
- Analysis of homozygous and heterozygous cell lines, including a deletion mutant.
Main Results:
- Tryptic peptide mapping of DR4-associated DR beta chains revealed minimal structural variation.
- Distinct peptide profiles were observed for Dw4 and Dw14 homozygous cells.
- HPLC analysis of a Dw4/Dw14 heterozygous cell line showed peptides corresponding to both specificities.
- Peptide variations precisely correlated with predicted amino acid sequences.
Conclusions:
- Amino acids 66-71 of the DR beta chain are implicated in structural and functional polymorphisms of HLA-D.
- This region contributes to the distinct characteristics of different HLA-DR specificities.
- Understanding these polymorphisms is vital for immunogenetic research and clinical applications.